Hulgan, Todd <br/><br/>
Oxidant stress is increased during treatment of human immunodeficiency virus infection.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Dec 2003 
 - 1711-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1086/379776  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>Antiretroviral Therapy, Highly Active<br/>F2-Isoprostanes--blood<br/>Female<br/>HIV Infections--blood<br/>HIV-1<br/>Humans<br/>Male<br/>Oxidants--metabolism<br/>Oxidative Stress